DW1809-1

DRUG2 trials

Sponsors

Daewon Pharmaceutical Co., Ltd.

Conditions

Acute Upper Respiratory Tract InfectionBack PainOsteoarthritisRheumatoid Arthritis

Phase 1

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809-T2

CompletedNCT05214690

Daewon Pharmaceutical Co., Ltd.Acute Upper Respiratory Tract Infection, Back Pain, Osteoarthritis +1

Start: 2020-08-13End: 2020-09-08Updated: 2022-01-31

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809

CompletedNCT05214677

Daewon Pharmaceutical Co., Ltd.Acute Upper Respiratory Tract Infection, Back Pain, Osteoarthritis +1

Start: 2020-08-15End: 2020-09-07Updated: 2022-01-31